Oxidative Damage and Antioxidative Therapy in Systemic Sclerosis

<table>The main mechanisms of oxidative stress in systemic sclerosis. NADPH oxidase: nicotinamide adenine dinucleotide phosphate-oxidase; oxLDL: oxidized low-density lipoprotein; ROS: reactive oxygen species; <svg height="14.5635pt" id="M2" style="vertical-align:-3.313601pt" version="1.1" viewbox="-0.0498162 -11.2499 25.3714 14.5635" width="25.3714pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0135,0,0,-0.0135,0,0)"><path d="M381 665C170 665 44 498 44 318C44 125 188 -15 369 -15C552 -15 703 117 703 333C703 534 550 665 381 665ZM359 629C491 629 601 517 601 306C601 114 502 21 390 21C249 21 146 158 146 346S248 629 359 629Z" id="g190-80"></path><glyph.data ascent="989" descent="-360" horiz-adv-x="747" vert-adv-y="747"></glyph.data></g><g transform="matrix(.0095,0,0,-0.0095,10.158,3.264)"><path d="M414 144C384 79 371 75 317 75H135L276 221C367 316 408 376 408 465C408 570 327 635 237 635C179 635 131 609 100 575L42 494L67 471C94 510 138 565 205 565C277 565 321 517 321 435C321 348 258 270 195 195C146 137 88 81 33 26V0H411C423 44 433 88 446 135L414 144Z" id="g50-51"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="487" vert-adv-y="487"></glyph.data></g><g transform="matrix(.0095,0,0,-0.0095,15.292,-5.984)"><path d="M333 262C333 337 270 397 193 397S54 337 54 262S116 127 193 127S333 187 333 262Z" id="g54-74"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="385" vert-adv-y="385"></glyph.data></g><g transform="matrix(.0095,0,0,-0.0095,18.944,-5.984)"><path d="M556 236V289H56V236H556Z" id="g54-33"></path><glyph.data ascent="3443" descent="-2856" horiz-adv-x="611" vert-adv-y="611"></glyph.data></g></svg>: superoxide anions.</table>

Mediators of Inflammation

Oxidative Damage and Antioxidative Therapy in Systemic Sclerosis

Figure 1